We use cookies and similar tools to give you the best website experience. By using our site, you accept our Websites Privacy Policy.
ÀÇÎѵ¼º½, In the Media, Translational Medicine
More than 70 percent of people in the clinical trial responded to the drug.
December 10, 2022
The PRECEDE Consortium aims to increase the 5-year survival rate to 50 percent within the next 10 years.
ÀÇÎѵ¼º½, In the Media
Dr. Sylvia Adams says new treatments are improving survival.
December 8, 2022
Dr. Paul E. Oberstein says a colorectal cancer tumor can become very large before symptoms present.
December 6, 2022
Dr. Joseph E. Ravenell says Black men should discuss the benefits and risks of screening with their doctors.
Dr. Jeffrey G. Schneider says people treated with initial chemotherapy should also receive immunotherapy.
December 1, 2022
Dr. Vamsidhar Velcheti says biomarker testing enables treatment to be tailored to a tumor’s vulnerability.
November 30, 2022
Dr. Joseph Ravenell says screening barriers contribute to Black men’s higher colorectal cancer death rates.
November 28, 2022
Dr. Jeffrey S. Weber says immunotherapies have reduced the risk of dying from this type of skin cancer.
Dr. Theodore H. Welling says immunotherapies are generally better tolerated than chemotherapy regimens.
We can help you find a doctor. Call 646-929-7800 or browse our specialists.
